ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
ZIOPHARM Oncology Inc
0.8657
0.0000
成交量：
- -
成交額：
191.07萬
市值：
1.86億
市盈率：
-2.06
高：
0.8657
開：
0.8657
低：
0.8657
收：
0.8657
52周最高：
5.95
52周最低：
0.7703
股本：
2.15億
流通股本：
1.72億
量比：
- -
換手率：
- -
股息：
- -
股息率：
- -
每股收益(TTM):
-0.4193
每股收益(LYR):
-0.3815
淨資產收益率：
-84.01%
總資產收益率：
-39.32%
市淨率：
2.70
市盈率(LYR):
-2.27
資料載入中...
總覽
公司
新聞資訊
公告
公司資料
公司名字：
ZIOPHARM Oncology Inc
交易所：
NASDAQ
成立時間：
- -
員工人數：
- -
公司地址：
- -
官網：
http://www.ziopharm.com
郵編：
- -
電話：
- -
傳真：
- -
簡介：
ZIOPHARM Oncology, Inc.最初於1998年9月在科羅拉多州註冊成立。該公司是一家生物製藥公司，旨在開發商業化的癌症藥物組合，這種組合可以解決未滿足的醫療需求。該公司的重點是許可和發展已經上市或正在開發的，與癌症治療有關的專有的小分子候選藥物，該種藥物可以通過靜脈和口服的方式供藥。該公司為它的小分子候選藥物進行了臨床試用項目，包括palifosfamide （ Zymafos或ZIO - 201 ） ，indibulin （ Zybulin或ZIO -301 ）和darinaparsin （ Zinapar或ZIO - 101 ）。目前，該公司正在與Intrexon公司共同在癌症治療方面尋求新的以DNA為基礎的生物療法。按照安排，公司在腫瘤研究方面有權使用Intrexon的效應平台，其中包括現有的兩個臨床階段的候選產品，ZIN - CTI - 001 （或DC -RTS - IL- 12 + AL）和ZIN - ATI的使用001 （或Ad -RTS - IL- 12 + AL） 。該公司計劃利用Intrexon的合成生物學平台開發產品，以刺激人體的免疫系統中用以抑制腫瘤生長和轉移的主要途徑，加強其小分子藥物開發組合，增加病人醫療裝置的科學性。有關palifosfamide ，darinaparsin和indibulin ，ZIN - CTI -001和ZIN -ATI -001的更多細節，以及其各自的臨床開發計劃更詳細的說明，將於本報告中“Business - Product Candidates”的標題下的文字中進行介紹。
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ZIOP/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ZIOP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ZIOP\",,,,,undefined,":{"symbol":"ZIOP","market":"US","secType":"STK","nameCN":"ZIOPHARM Oncology Inc","latestPrice":0.8657,"timestamp":1643230800000,"preClose":0.8657,"halted":8,"volume":0,"delay":0,"changeRate":0,"floatShares":172416947,"shares":214635171,"eps":-0.419301,"marketStatus":"已收盤","change":0,"latestTime":"01-26 16:00:00 EST","open":0.8657,"high":0.8657,"low":0.8657,"amount":1910670.044435,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.419301,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1773216000000},"marketStatusCode":5,"symbolChange":{"newSymbol":"TCRT","executeDate":"2022-01-27"},"adr":0,"adrRate":0,"listingDate":1158897600000,"exchange":"NASDAQ","adjPreClose":0.8657,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ZIOP\",,,,,undefined,":{"symbol":"ZIOP","floatShares":172416947,"roa":"-39.32%","roe":"-84.01%","lyrEps":-0.381498,"shares":214635171,"dividePrice":0,"high":0.8657,"amplitude":0,"preClose":0.8657,"low":0.8657,"week52Low":0.7703,"pbRate":"2.70","week52High":5.95,"institutionHeld":0.4932,"latestPrice":0.8657,"eps":-0.419301,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.419301,"open":0.8657},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ZIOP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2022-01-27","symbol":"ZIOP","oldSymbol":"ZIOP","defaultRemindTime":1643293800000,"newSymbol":"TCRT","exchange":"NASDAQ","type":"symbolChange","dateTimestamp":1643259600000},{"market":"US","date":"2021-11-08","symbol":"ZIOP","fiscalQuarterEnding":"2021/09","expectedEps":-0.15,"name":null,"time":"盤後","type":"earning","dateTimestamp":1636347600000,"reportTimeType":"post","actualEps":-0.11},{"market":"US","date":"2021-08-13","symbol":"ZIOP","fiscalQuarterEnding":"2021/06","expectedEps":-0.14,"name":null,"time":"盤後","type":"earning","dateTimestamp":1628827200000,"reportTimeType":"post","actualEps":-0.11},{"market":"US","date":"2021-05-06","symbol":"ZIOP","fiscalQuarterEnding":"2021/03","expectedEps":-0.11,"name":null,"time":"盤後","type":"earning","dateTimestamp":1620273600000,"reportTimeType":"post","actualEps":-0.1},{"market":"US","date":"2021-02-25","symbol":"ZIOP","fiscalQuarterEnding":"2020/12","expectedEps":-0.1,"name":null,"time":"盤後","type":"earning","dateTimestamp":1614229200000,"reportTimeType":"post","actualEps":-0.11}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ZIOP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ZIOP\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ZIOP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ZIOP","date":"2022-01-26","current":-2.064627,"percent":0.992783,"low":-20.203787,"twenty":-12.834139,"median":-6.540845,"eighty":-3.929646,"high":-1.886403,"avg":-7.975749,"sd":4.514557,"marketCap":187462358},"quantilePoints":[{"date":"2021-03-12","current":-12.890179,"twenty":-13.639627,"median":-6.983843,"eighty":-4.448539,"marketCap":1030904993},{"date":"2021-03-19","current":-10.40307,"twenty":-13.448637,"median":-6.980647,"eighty":-4.444529,"marketCap":831995938},{"date":"2021-03-26","current":-9.893038,"twenty":-13.386804,"median":-6.983843,"eighty":-4.448539,"marketCap":791205571},{"date":"2021-04-01","current":-9.651744,"twenty":-13.355888,"median":-6.983843,"eighty":-4.448539,"marketCap":771907874},{"date":"2021-04-09","current":-9.088726,"twenty":-13.217964,"median":-6.980647,"eighty":-4.444529,"marketCap":726879915},{"date":"2021-04-16","current":-9.182562,"twenty":-13.012807,"median":-6.980647,"eighty":-4.444529,"marketCap":734384574},{"date":"2021-04-23","current":-8.981484,"twenty":-12.954191,"median":-6.980647,"eighty":-4.444529,"marketCap":718303160},{"date":"2021-04-30","current":-9.249588,"twenty":-12.895575,"median":-6.980647,"eighty":-4.444529,"marketCap":739745046},{"date":"2021-05-07","current":-8.01631,"twenty":-12.861225,"median":-6.980647,"eighty":-4.444529,"marketCap":641112373},{"date":"2021-05-14","current":-8.123815,"twenty":-12.836693,"median":-6.980647,"eighty":-4.444529,"marketCap":649710189},{"date":"2021-05-21","current":-8.037393,"twenty":-12.836693,"median":-6.980647,"eighty":-4.444529,"marketCap":669008511},{"date":"2021-05-28","current":-7.857067,"twenty":-12.836693,"median":-6.980647,"eighty":-4.444529,"marketCap":653998705},{"date":"2021-06-04","current":-8.063154,"twenty":-12.836693,"median":-6.980647,"eighty":-4.444529,"marketCap":671152769},{"date":"2021-06-11","current":-7.470654,"twenty":-12.836693,"median":-6.980647,"eighty":-4.444529,"marketCap":621834834},{"date":"2021-06-18","current":-7.161524,"twenty":-12.836693,"median":-6.980647,"eighty":-4.444529,"marketCap":596103737},{"date":"2021-06-25","current":-7.213045,"twenty":-12.841599,"median":-6.953718,"eighty":-4.444529,"marketCap":600392254},{"date":"2021-07-02","current":-7.032719,"twenty":-12.841599,"median":-6.947905,"eighty":-4.444529,"marketCap":585382447},{"date":"2021-07-09","current":-6.543263,"twenty":-12.841599,"median":-6.929676,"eighty":-4.444529,"marketCap":544641544},{"date":"2021-07-16","current":-6.002284,"twenty":-12.841599,"median":-6.910594,"eighty":-4.444529,"marketCap":499612125},{"date":"2021-07-23","current":-5.925002,"twenty":-12.841599,"median":-6.910594,"eighty":-4.444529,"marketCap":493179351},{"date":"2021-07-30","current":-5.796197,"twenty":-12.841599,"median":-6.910594,"eighty":-4.444529,"marketCap":482458061},{"date":"2021-08-06","current":-5.950762,"twenty":-12.841599,"median":-6.910594,"eighty":-4.444529,"marketCap":495323609},{"date":"2021-08-13","current":-4.817284,"twenty":-12.841599,"median":-6.910594,"eighty":-4.444529,"marketCap":400976255},{"date":"2021-08-20","current":-3.537599,"twenty":-12.841599,"median":-6.901313,"eighty":-4.419575,"marketCap":308871321},{"date":"2021-08-27","current":-4.127199,"twenty":-12.851412,"median":-6.899989,"eighty":-4.405891,"marketCap":360349874},{"date":"2021-09-03","current":-4.348299,"twenty":-12.851412,"median":-6.899989,"eighty":-4.358744,"marketCap":379654332},{"date":"2021-09-10","current":-4.716799,"twenty":-12.851412,"median":-6.899989,"eighty":-4.348711,"marketCap":411828428},{"date":"2021-09-17","current":-4.151766,"twenty":-12.851412,"median":-6.899989,"eighty":-4.320742,"marketCap":362494814},{"date":"2021-09-24","current":-5.232699,"twenty":-12.851412,"median":-6.879713,"eighty":-4.320742,"marketCap":456872162},{"date":"2021-10-01","current":-4.471132,"twenty":-12.851412,"median":-6.878251,"eighty":-4.320742,"marketCap":390379030},{"date":"2021-10-08","current":-4.421999,"twenty":-12.846506,"median":-6.87714,"eighty":-4.321738,"marketCap":386089151},{"date":"2021-10-15","current":-4.299166,"twenty":-12.846506,"median":-6.873582,"eighty":-4.301202,"marketCap":375364452},{"date":"2021-10-22","current":-4.028932,"twenty":-12.846506,"median":-6.863512,"eighty":-4.261013,"marketCap":351770115},{"date":"2021-10-29","current":-3.783266,"twenty":-12.841599,"median":-6.858112,"eighty":-4.228948,"marketCap":330320718},{"date":"2021-11-05","current":-4.028932,"twenty":-12.841599,"median":-6.858112,"eighty":-4.153102,"marketCap":351770115},{"date":"2021-11-12","current":-3.635898,"twenty":-12.841599,"median":-6.825712,"eighty":-4.150208,"marketCap":326245459},{"date":"2021-11-19","current":-3.420614,"twenty":-12.841599,"median":-6.800871,"eighty":-4.126435,"marketCap":306928294},{"date":"2021-11-26","current":-3.229251,"twenty":-12.841599,"median":-6.77511,"eighty":-4.106566,"marketCap":289757480},{"date":"2021-12-03","current":-3.15749,"twenty":-12.841599,"median":-6.73931,"eighty":-4.097072,"marketCap":283318425},{"date":"2021-12-10","current":-3.085729,"twenty":-12.841599,"median":-6.662632,"eighty":-4.074366,"marketCap":276879370},{"date":"2021-12-17","current":-2.822605,"twenty":-12.841599,"median":-6.607312,"eighty":-4.028932,"marketCap":253269501},{"date":"2021-12-23","current":-3.037888,"twenty":-12.841599,"median":-6.564515,"eighty":-4.026453,"marketCap":272586667},{"date":"2021-12-31","current":-2.679082,"twenty":-12.836693,"median":-6.553889,"eighty":-4.007035,"marketCap":240391391},{"date":"2022-01-07","current":-2.439879,"twenty":-12.835416,"median":-6.543263,"eighty":-3.979799,"marketCap":218927874},{"date":"2022-01-14","current":-2.112169,"twenty":-12.834139,"median":-6.540845,"eighty":-3.964041,"marketCap":189522855},{"date":"2022-01-21","current":-2.059545,"twenty":-12.834139,"median":-6.540845,"eighty":-3.951733,"marketCap":184800882},{"date":"2022-01-26","current":-2.089206,"twenty":-12.834139,"median":-6.540845,"eighty":-3.929646,"marketCap":187462358}],"updateTime":1773197348388},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.ziopharm.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0118},{"period":"1month","weight":-0.0179},{"period":"3month","weight":-0.007},{"period":"6month","weight":0.04},{"period":"1year","weight":0.1777},{"period":"ytd","weight":-0.0054}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"ZIOPHARM Oncology, Inc.最初於1998年9月在科羅拉多州註冊成立。該公司是一家生物製藥公司，旨在開發商業化的癌症藥物組合，這種組合可以解決未滿足的醫療需求。該公司的重點是許可和發展已經上市或正在開發的，與癌症治療有關的專有的小分子候選藥物，該種藥物可以通過靜脈和口服的方式供藥。該公司為它的小分子候選藥物進行了臨床試用項目，包括palifosfamide （ Zymafos或ZIO - 201 ） ，indibulin （ Zybulin或ZIO -301 ）和darinaparsin （ Zinapar或ZIO - 101 ）。目前，該公司正在與Intrexon公司共同在癌症治療方面尋求新的以DNA為基礎的生物療法。按照安排，公司在腫瘤研究方面有權使用Intrexon的效應平台，其中包括現有的兩個臨床階段的候選產品，ZIN - CTI - 001 （或DC -RTS - IL- 12 + AL）和ZIN - ATI的使用001 （或Ad -RTS - IL- 12 + AL） 。該公司計劃利用Intrexon的合成生物學平台開發產品，以刺激人體的免疫系統中用以抑制腫瘤生長和轉移的主要途徑，加強其小分子藥物開發組合，增加病人醫療裝置的科學性。有關palifosfamide ，darinaparsin和indibulin ，ZIN - CTI -001和ZIN -ATI -001的更多細節，以及其各自的臨床開發計劃更詳細的說明，將於本報告中“Business - Product Candidates”的標題下的文字中進行介紹。","yearOnYearQuotes":[{"month":1,"riseRate":0.529412,"avgChangeRate":0.098271},{"month":2,"riseRate":0.625,"avgChangeRate":0.091033},{"month":3,"riseRate":0.4375,"avgChangeRate":-0.01728},{"month":4,"riseRate":0.6875,"avgChangeRate":0.028507},{"month":5,"riseRate":0.5,"avgChangeRate":0.095157},{"month":6,"riseRate":0.4375,"avgChangeRate":-0.032893},{"month":7,"riseRate":0.3125,"avgChangeRate":-0.019105},{"month":8,"riseRate":0.3125,"avgChangeRate":-0.076923},{"month":9,"riseRate":0.625,"avgChangeRate":0.062835},{"month":10,"riseRate":0.4375,"avgChangeRate":-0.025516},{"month":11,"riseRate":0.647059,"avgChangeRate":0.067971},{"month":12,"riseRate":0.294118,"avgChangeRate":-0.127992}],"exchange":"NASDAQ","name":"ZIOPHARM Oncology Inc","nameEN":"ZIOPHARM Oncology"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ZIOP\",market:\"US\",,,undefined,":null}}